PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | |diabetes |
| Sentences | 70 |
| PubMedID- 22201932 | Non alcoholic fatty liver disease (nafld) is associated with obesity, diabetes and insulin resistance (ir). |
| PubMedID- 21932714 | diabetes is associated with chronic liver disease and liver cancer in the adult population of puerto rico. |
| PubMedID- 26509504 | Various liver diseases are associated with diabetes [18,19]. |
| PubMedID- 26573193 | Objective: to explore the relationship between socioeconomic status (ses) and non-alcoholic fatty liver disease (nafld) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 20096896 | Recent evidence has suggested an association between microalbuminuria and ultrasound-diagnosed nonalcoholic fatty liver disease (nafld) in patients with diabetes and prediabetes. |
| PubMedID- 21642744 | Akr1b7 may be a therapeutic target for treatment of fatty liver disease associated with diabetes mellitus. |
| PubMedID- 26322515 | As shown earlier, elevated ggt levels are considered a marker for non-alcoholic fatty liver disease and are associated with diabetes, arterial hypertension and cardiovascular diseases [29, 30], [31]. |
| PubMedID- 21601719 | Risk factors for development of liver disease for patients with bipolar disorder: diabetes (or=1.40), hiv (or=3.66), sud (or=2.68), alcohol use disorder (or=3.22) and bipolar disorder (or=2.27). |
| PubMedID- 21664213 | Due to the worldwide surge in obesity and type 2 diabetes, the increased incidence of nonalcoholic fatty liver disease (nafld) is a major concern for the public health. |
| PubMedID- 24625618 | Er stress has been closely linked to various human diseases including inflammatory diseases, cardiovascular diseases, diabetes, and all types of human liver diseases [10]. |
| PubMedID- 19758274 | By multivariate analysis, age > or = 65 years, alcohol consumption and diabetes were independently associated with advanced liver disease. |
| PubMedID- 25961500 | Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease. |
| PubMedID- 26315331 | Background: liver disease in diabetes is common and is frequently the result of hepatic steatosis. |
| PubMedID- 22024083 | Sitagliptin as a novel treatment agent for non-alcoholic fatty liver disease patients with type 2 diabetes mellitus. |
| PubMedID- 26005676 | Fatty liver disease in diabetes mellitus. |
| PubMedID- 23433228 | Previous studies reported associations of diabetes with chronic liver disease [41] and various types of cancer [42]. |
| PubMedID- 23578506 | Objective: to explore the liver disease spectrum in patients with type 2 diabetes (t2dm) and the risk factors of non-alcoholic fatty liver disease (nafld). |
| PubMedID- 24071688 | Objective: to observe the effect of metformin on the expression of sirt1 and ucp2 in rat liver of type 2 diabetes mellitus (t2dm) with nonalcoholic fatty liver disease (nafld), and discuss the pathogenesis of t2dm with nafld, and the treatment with and possible mechanism of metformin. |
| PubMedID- 23332087 | This critical review of the published work aims to highlight the most recent basic and clinical data underlying the development of type 2 diabetes, in those with non-alcoholic fatty liver disease. |
| PubMedID- 23954219 | Objective: to investigate the relationship between the resistin intronic +299g/a polymorphism and nonalcoholic fatty liver disease (nafld) in patients with type 2 diabetes mellitus (t2dm). |
Page: 1 2